Type I Diabetes Models and Efficacy Services

Anti-Tumor Drug Efficacy Evaluation
Humanized Immune Checkpoint Mouse Models and Efficacy Services
Autoimmune Disease Efficacy Evaluation
Autoimmune Nephropathy Models and Efficacy ServicesAsthma Models and Efficacy ServicesSystemic Lupus Erythematosus (SLE) Models and Efficacy ServicesSjögren's Syndrome Models and Efficacy ServicesNeuroimmune Diseases Models and Efficacy ServicesAutoimmune Dermatoses Models and Efficacy ServicesInflammatory Bowel Disease (IBD) Models and Efficacy ServicesRheumatoid Arthritis (RA) Models and Efficacy ServicesImmune Reconstitution Autoimmune Disease Models and Efficacy Services
Metabolic Disease Efficacy Evaluation
Obesity Models and Efficacy ServicesType II Diabetes Models and Efficacy ServiceType I Diabetes Models and Efficacy ServicesAndrogenetic Alopecia (AGA) Models and Efficacy ServicesMASH Models and Efficacy ServicesChronic Liver Fibrosis Models and Efficacy ServicesAcute Liver Injury Models and Efficacy ServicesCholestasis Models and Efficacy ServicesAlcohol-related Liver Disease (ALD) Models and Efficacy ServicesChronic Kindey Disease (CKD) Models and Efficacy ServicesActue Kindey Disease (AKD) Models and Efficacy ServicesDiabetes Nephropathy (Diabetic Kidney Disease) Models and Efficacy ServicesSarcopenia Models and Efficacy ServicesGout/Hyperuricemia Models and Efficacy ServicesFemale Reproduction Models and Efficacy Services
Neurological Disease Efficacy Evaluation
In Vitro TestingBehavioral AnalysisIn Vivo Drug Efficacy EvaluationIn Vivo Biochemical ExaminingParkinson’s Disease Rat Model
Cardiovascular Diseases Efficacy Evaluation
Heart Failure Models and Efficacy ServicesHypertension Models and Efficacy ServicesAtherosclerosis Models and Efficacy ServicesAdvanced Cardiovascular and Metabolic Complication Models and Efficacy ServicesHyperlipidemia Models and Efficacy ServicesHypertropic Cardiomyopathy Models and Efficacy ServicesStroke Models and Efficacy ServicesThrombosis Models and Efficacy Services
Bioanalytical Services
Phenotyping Services
Oncology PlatformMetabolism PlatformEfficacy and Pathology Platform
Non-GLP Toxicity Assessment Services
Cell Therapy & Gene Therapy Efficacy Evaluation
Disease Rat Models
60% HFD Induced DIO Rat ModelsAdenine-induced Rat CKD Model5/6 Nephrectomy-induced Rat CKD ModelCCL4-induced Chronic Liver Fibrosis Models in SD RatCDAHFD-induced Rat MASH Model45％HFHS+STZ induced Type I Diabetes Models in SD RatOVX-induced Rat Osteoporosis ModelMCAO-induced CIS Model in SD Rat2K1C-induced Hypertension Model in SD Rat

STZ induced TID models


Streptozotocin (STZ) is a widely used chemical agent used to induce type 1 diabetes in rodent models, including NCG and C57BL/6J (B6) mice. STZ selectively destroys pancreatic beta cells via necrosis, leading to insulin deficiency and hyperglycemia. This model is valuable for studying the pathophysiology of type 1 diabetes and testing potential therapeutic interventions.

 

Study outline


图片1.png


1. STZ-Induced Type I Diabetes in NCG Mice


1.1 NCG mice show increased blood glucose level and decreased plasma insulin after STZ exposure.

 

图片2.png

图片3.png

Data presented as mean±SEM,**,****denoted p<0.01, p<0.0001 vs NCG+Vehicle, respectively.

 

1.2 STZ induced aggravation of islet damage: the number of islets decreased, the shape was irregular, and islets boundary was unclear with duct enlarged.

 

图片4.png

 

2. STZ-Induced Type I Diabetes in C57BL/6J Mice


2.1 B6 mice show increased blood glucose level after STZ exposure.


图片5.png 

Data request in progress, please wait…